Revenue segments as reported by the company.

Cannabis revenue

Distribution revenue

Beverage alcohol revenue

Wellness revenue

Adult-use

Canada - Medical

International - Medical

Bulk

Hemp

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Impairment of Assets

Litigation settlement

Transaction costs

Change in fair value of contingent consideration

Restructuring costs

Other than temporary change in fair value of convertible notes receivable

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Tilray Brands

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. The firm is focused on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment consists of hemp seed, hemp foods, and broad spectrum hemp extract containing CBD, which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Earnings data Q1 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Tilray Brands reports record revenue and optimistic outlook for 2025

Tilray Brands achieved remarkable financial performance in Q4 2024, driven by strategic acquisitions and a focus on innovation. Despite challenges like price compression, the company remains optimistic about future growth opportunities. Tilray's commitment to quality products and innovation positions it well for continued success in the market.

Tilray Brands reports record Q1 revenue growth and global expansion

Tilray Brands delivered a robust performance in Q1 2025, showcasing strong revenue growth, margin improvement, and strategic expansion across its diversified product portfolio.
While facing challenges in a competitive landscape and evolving regulatory environment, Tilray's financial strength, international growth initiatives, and focus on innovation position it well for future success.
By capitalizing on opportunities in wellness products, expanding into new beverage categories, and leveraging strategic partnerships, Tilray is poised for continued growth and market leadership.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. The Cannabis Business segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution Business segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage Alcohol Business segment refers to the production, marketing, and sale of beverages. The Wellness Business segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Valuation still high prior to Aphria merger. Higher interest rates have hurt growth names. Another meaningful capital raise likely needed.

Tilray: Wait A Little Longer

Aurora Cannabis

Aphria

Canopy Growth

HEXO Corp

OrganiGram Holdings Inc.

It's about what's happening in a potentially powerful marijuana state.

Why These Top Marijuana Stocks Got Slammed Today

Tilray has cooled down from its massive run this year, fueled by U.S. legalization prospects. Is TLRY stock a buy right now?

Is Tilray Stock A Buy After Shoring Up Key Support Level?

The stock price of Tilray, Inc. (NASDAQ: TLRY) increased by 10.5%. This is why it happened.

TLRY Stock Price Increased 10.5%: Why It Happened

Tilray Inc. (NASDAQ:TLRY) shares jumped Monday after the company announced it will hold a meeting to approve the proposed Tilray-Aphria Inc (NASDAQ:APHA) business combination.   The meeting will be held Friday, April 16.

Tilray Stock Trades Green: Technical Levels To Watch

Cronos Group

Cannabis stocks moved higher on Monday after Governor Andrew Cuomo said New York is "very close" on legalizing the drug for recreational use. Shares of Tilray and Aphria traded up as much as 14% and 12%, respectively, while marijuana ETFs like the ETFMG Alternative Harvest and AdvisorShares Pure Cannabis ETFs were up as much as 4%.

Cannabis stocks surge after Governor Andrew Cuomo says New York is 'very close' on legalization

New York could be very close to legalizing recreational marijuana.

Why Canopy Growth, Hexo, Tilray, and Other Pot Stocks Soared Today

Macy's

One of the most common questions traders have about stocks is “Why Is It Moving?” That's why Benzinga created the Why Is It Moving, or WIIM, feature in Benzinga Pro.

Is Now The Time To Buy OGI Stock, TLRY Stock Or M Stock?

The companies are one step closer to a merger.

Why Aphria and Tilray Stocks Jumped Monday

Tilray to Host Special Meeting of Stockholders on Friday, April 16, 2021 to Approve Proposed Aphria-Tilray Business Combination Proxy Materials Mailed to Aphria Shareholders and Tilray Stockholders of Record as of Friday, March 12, 2021 Required Regulatory Approvals Contemplated Under the Arrangement Agreement Received in Respect of the Proposed Business Combination The Boards of Directors of Aphria and Tilray Unanimously Recommend that their Respective Shareholders Vote "FOR" the Transaction Shareholders of Aphria and Stockholders of Tilray are Encouraged to Visit www.aphriatilraytogether.com for Up-to-Date Information About the Proposed Aphria-Tilray Business Combination LEAMINGTON, ON and NANAIMO, BC, March 15, 2021 /PRNewswire/ - Aphria Inc. ("Aphria") (TSX: APHA and Nasdaq: APHA), a leading global cannabis-lifestyle consumer packaged goods company‎, and Tilray, Inc. ("Tilray") (Nasdaq: TLRY), a global pioneer in cannabis research, cultivation, production and distribution, are pleased to announce that: (i)  Aphria has obtained an interim order (the "Interim Order") of the Ontario Superior Court of Justice (Commercial List) (the "Court") in connection with its proposed business combination with Tilray pursuant to an arrangement (the "Arrangement") to be implemented under a statutory plan of arrangement pursuant to section 182 of the Business Corporations Act (Ontario); (ii)  They have received the required regulatory approvals necessary to complete the proposed business combination between the two companies (the "Transaction"); (iii)  They have filed their joint proxy statement/management information circular (collectively, the "Circular") ‎and related materials (the "Meeting Materials") in respect of the special meeting of Aphria shareholders ‎‎(the "Aphria Shareholders") to be held on April 14, 2021 (the "Aphria Meeting") and the special meeting ‎of the holders (the "Tilray Stockholders") of the Tilray class 2 common stock (the "Tilray ‎Shares")‎ ‎to be held on April 16, 2021 (the "Tilray Meeting"), to approve the resolutions necessary to ‎implement the Arrangement; and (iv)  The record date for ‎determining the Aphria Shareholders and the Tilray Stockholders entitled to receive notice of and vote at the Aphria Meeting and the Tilray Meeting, respectively, ‎was fixed by each of Aphria and Tilray to be the close of ‎business on March 12, 2021‎.‎ Irwin D.

Aphria to Host Special Meeting of Shareholders on Wednesday, April 14, 2021 to Approve Proposed Aphria-Tilray Business Combination

Their upcoming merger is exciting, but it may not solve some existing issues.

2 Green Flags and 2 Red Flags for Tilray and Aphria

NEW YORK, March 12, 2021 /PRNewswire/ -- Juan Monteverde , founder and managing partner at Monteverde & Associates PC, a national securities firm rated Top 50 in the 2018 and 2019 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York City, is investigating  Tilray, Inc. ("TLRY" or "the Company") ( TLRY ) relating to its proposed merger with Aphria, Inc. Under the terms of the agreement, Aphria shareholders will receive 0.8381 shares of Tilray per share. The investigation focuses on whether Tilray, Inc. and its Board of Directors violated securities laws and/or breached their fiduciary duties to the Company by 1) failing to conduct a fair process, and 2) whether the transaction is properly valued.

SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Tilray, Inc. - TLRY

Arena Pharmaceuticals

British American Tobacco

Innovative Industrial Properties

Akerna Corp

cbdMD Inc

Zynerba Pharmaceuticals

Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week, and look ahead to how the cannabis industry will continue to develop in the 2021.

8 Cannabis Stocks on Fire After Corporate Moves

Akers Biosciences

Cleveland BioLabs

NEW YORK, March 12, 2021 /PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights or interests, please contact:                                                                                  CONTACT:                                                                           Joshua Rubin, Esq.                                                                               WeissLaw LLP                                                                    1500 Broadway, 16th Floor                                                                        New York, NY  10036                                                                             (212) 682-3025                                                                             (888) 593-4771                                                                   stockinfo@weisslawllp.com Newtown Lane Marketing, Inc. (OTC: NTWN) WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Newtown Lane Marketing, Inc. (OTC: NTWN) in connection with the company's proposed merger with Appgate.

SHAREHOLDER ALERT: WeissLaw LLP Reminds NTWN, TLRY, CBLI, and AKER Shareholders About Its Ongoing Investigations

This options spread is a limited risk way to profit from a continued rally in Tilray (TLRY) stock on the heels of a 17% one-day rally. The post TLRY Stock: Low Risk, High Return Option Play appeared first on Investor's Business Daily.

TLRY Stock: Low Risk, High Return Option Play

GrowGeneration Corp

Mexico is getting closer to legalizing marijuana and the news has shares of several weed stocks heading higher on Thursday. The post Weed Stocks: ACB, CGC, TLRY, GRWG, APHA, CRON Light Up on Mexico Marijuana Legalization News appeared first on InvestorPlace.

Weed Stocks: ACB, CGC, TLRY, GRWG, APHA, CRON Light Up on Mexico Marijuana Legalization News

Its shares are up by more than 300% since early November.

Could Tilray Be a Millionaire-Maker Stock?

The cannabis producer is entering a new market.

Why Tilray Stock Is Rising Today

Apple

Carnival

SNDL Inc.

Is Now The Time To Buy Stock In Sundial Growers, Tilray, Apple Or Carnival?

NANAIMO, British Columbia--(BUSINESS WIRE)--Tilray, Inc. (NASDAQ: TLRY), a global pioneer in cannabis research, cultivation, production, and distribution, today announced that it has received the necessary approvals from New Zealand's Ministry of Health and the Medicinal Cannabis Agency to launch Tilray medical cannabis products across the country. Tilray is one of the leading providers of medical cannabis in Australia and New Zealand for commercial, compassionate access, and research purposes

Tilray® Receives Approvals to Expand and Commercialize Medical Cannabis Products in New Zealand

Curaleaf Holdings, Inc.

Green Thumb Industries Inc.

Amplify Alternative Harvest ETF

AdvisorShares Pure US Cannabis ETF

Trulieve Cannabis Corp.

Alpha Trader Talks Cannabis Investing With Todd Harrison (Podcast)

Investors in TLRY stock have been on a very turbulant ride of late, and it's likely that this volatility will continue for some time. The post Tilray Could Have Much More Downside on the Horizon appeared first on InvestorPlace.

Tilray Could Have Much More Downside on the Horizon

It's not the worst idea to invest in the world's largest marijuana grower by revenue.

Is Tilray Stock a Buy?

Cannabis growers and distributors dropped for a second straight week, falling with the broader market and on increased concerns about partisan sniping.

Cannabis stocks slump for second straight week as prospects dim for nationwide legalization

Pot stocks like CGC, TLRY, APHA and SNDL stock are down today as investors shift risk preferences and eye inflation rates. The post CGC, TLRY, APHA and SNDL: Why Are Pot Stocks Down Today?

CGC, TLRY, APHA and SNDL: Why Are Pot Stocks Down Today?

News for Tilray Brands Stock (TLRY)